[The aryl hydrocarbon receptor as the target structure for new drugs in psoriasis and atopic dermatitis].

[1]  Gang Wang,et al.  A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor. , 2019, The Journal of allergy and clinical immunology.

[2]  J. Peppers,et al.  Phase 2, randomized dose‐finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis , 2019, Journal of the American Academy of Dermatology.

[3]  A. Paller,et al.  A phase 2, randomized dose‐finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis , 2019, Journal of the American Academy of Dermatology.

[4]  T. Collingwood,et al.  Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study , 2018, Clinical pharmacology in drug development.

[5]  J. Krutmann,et al.  Environment and Skin , 2017, Springer International Publishing.

[6]  T. Willson,et al.  Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. , 2017, The Journal of investigative dermatology.

[7]  A. Johnston.  Resolving Inflammation by Targeting an Ancient Innate Immune Sensor with a Bacterial Metabolite. , 2017, The Journal of investigative dermatology.

[8]  M. E. Hahn,et al.  Diversity as Opportunity: Insights from 600 Million Years of AHR Evolution. , 2017, Current opinion in toxicology.

[9]  K. Köhrer,et al.  Aryl Hydrocarbon Receptor in Keratinocytes Is Essential for Murine Skin Barrier Integrity. , 2016, The Journal of investigative dermatology.

[10]  H. Merk.  Zentraler Zellsensor für Umwelteinflüsse , 2016, Allergo Journal.

[11]  M. Suárez-Fariñas,et al.  Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer. , 2016, The Journal of allergy and clinical immunology.

[12]  J. Bergman,et al.  Evidence for New Light-Independent Pathways for Generation of the Endogenous Aryl Hydrocarbon Receptor Agonist FICZ. , 2016, Chemical research in toxicology.

[13]  C. Esser,et al.  The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders. , 2015, The Journal of investigative dermatology.

[14]  C. Esser,et al.  The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology , 2015, Pharmacological Reviews.

[15]  S. Amin,et al.  Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation , 2015, The Journal of investigative dermatology.

[16]  Frank O. Nestle,et al.  Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions , 2014, Immunity.

[17]  Winfried Schuller,et al.  The Aryl hydrocarbon receptor is involved in UVR-induced immunosuppression. , 2013, The Journal of investigative dermatology.

[18]  C. Esser,et al.  Functions of the aryl hydrocarbon receptor in the skin , 2013, Seminars in Immunopathology.

[19]  A. Skaltsounis,et al.  Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. , 2013, The Journal of investigative dermatology.

[20]  A. Irvine,et al.  Old King coal - molecular mechanisms underlying an ancient treatment for atopic eczema. , 2013, The Journal of clinical investigation.

[21]  J. Schalkwijk,et al.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. , 2013, The Journal of clinical investigation.

[22]  L. Kiemeney,et al.  DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar. , 2012, Toxicology letters.

[23]  R. Bissonnette,et al.  Efficacy and safety of topical WBI‐1001 in patients with mild to severe atopic dermatitis: results from a 12‐week, multicentre, randomized, placebo‐controlled double‐blind trial , 2012, The British journal of dermatology.

[24]  R. Bissonnette,et al.  Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[25]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[26]  L. Kiemeney,et al.  No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. , 2010, The Journal of investigative dermatology.

[27]  Youwen Zhou,et al.  Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial. , 2010, Archives of dermatology.

[28]  B. Stockinger,et al.  The aryl hydrocarbon receptor in immunity. , 2009, Trends in immunology.

[29]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[30]  L. Klotz,et al.  Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation , 2007, Proceedings of the National Academy of Sciences.

[31]  A. Rannug,et al.  The aryl hydrocarbon receptor and light , 2006, Biological chemistry.

[32]  F. Perera,et al.  Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  H. Mukhtar,et al.  Monoclonal antibodies directed characterization of epidermal and hepatic cytochrome P-450 isozymes induced by skin application of therapeutic crude coal tar. , 1989, The Journal of investigative dermatology.

[34]  H. Mukhtar,et al.  Benzo(a)pyrene diol epoxide-I-DNA adduct formation in the epidermis and lung of SENCAR mice following topical application of crude coal tar. , 1986, Cancer letters.

[35]  H. Mukhtar,et al.  Pharmacological modification of epidermal detoxification systems , 1986, The British journal of dermatology.

[36]  H. Merk,et al.  [Tar treatment in dermatology]. , 1983, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[37]  H. Mukhtar,et al.  Effect of topical application of defined constituents of coal tar on skin and liver aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase activities. , 1982, Toxicology and applied pharmacology.

[38]  H. Mukhtar,et al.  Induction of neonatal rat skin and liver aryl hydrocarbon hydroxylase by coal tar and its constituents. , 1982, The Journal of investigative dermatology.

[39]  D. Bickers.  The carcinogenicity and mutagenicity of therapeutic coal tar--a perspective. , 1981, The Journal of investigative dermatology.

[40]  D. Bickers,et al.  Human skin aryl hydrocarbon hydroxylase. Induction by coal tar. , 1978, The Journal of clinical investigation.

[41]  W. Heymann.  "Tar smarts" may have a new meaning for atopic dermatitis and psoriasis. , 2019, Journal of the American Academy of Dermatology.

[42]  T. Kraus,et al.  POPs and Skin , 2018 .

[43]  L. Kiemeney,et al.  Dermatological exposure to coal tar and bladder cancer risk: a case-control study. , 2015, Urologic oncology.

[44]  H. Mukhtar,et al.  Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. , 1987, The Journal of investigative dermatology.

[45]  H. Merk,et al.  [Tar treatment of psoriasis]. , 1985, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.